Wouldn’t worry about monkeypox, cuts drug costs for low-income

Wouldn’t worry about monkeypox, cuts drug costs for low-income 0

May 25, 2022

Albert Bourla, Pfizer CEO, at the WEF in Davos, Switzerland on May 25th, 2022. Adam Galici | CNBC Pfizer‘s CEO said Wednesday that he “wouldn’t worry much” about a recent monkeypox outbreak that has seen cases surge in non-endemic countries. Albert Bourla told CNBC that current data on the disease suggests it doesn’t transmit as

‘Cheap’ stocks to buy to beat rising prices, slowing growth: Strategists 0

Business

May 24, 2022

The global economy is beset with rising inflation and slowing growth. Here, CNBC Pro sifts through recent research notes to identify strategists’ top stocks in this tricky environment. The U.S. Federal Reserve hiked rates in March for the first time in more than three years, and announced a further 50-basis-point hike earlier this month .

When the market was tanking, these stocks were hitting all-time highs 0

Business

May 24, 2022

While market losses were racking up, this group of stocks was breaking out to all-time highs and looks set for even more gains. The group is Big Pharma. It’s been long viewed as stodgy by investors looking for quicker price gains. Recently, however, as other stocks slid, these companies have become more attractive because of

Novavax confident Covid vaccine will receive FDA authorization in June after delays 0
- Business
- May 13, 2022
Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is scheduled to meet on June 7 to review Novavax’s submission. An endorsement from the committee, which is made up of independent experts, would mean the drug
READ MORE
These stocks sport big and safe dividends for this uncertain market 0
- Business
- May 11, 2022
CNBC Pro found stocks with outsized and steady dividends that provide consistent income even as share prices struggle. Source link
READ MORE
Peloton, Upstart, Vroom and more 0
- Business
- May 10, 2022
A Peloton Interactive Inc. logo on a stationary bike at the company’s showroom in Dedham, Massachusetts, U.S., on Wednesday, Feb. 3, 2021. Adam Glanzman | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Peloton – Shares tumbled 12% after the equipment maker disclosed it’s piling up excess inventory and burning through
READ MORE

Pfizer Inc